Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.63 |
| ▸ | TPMT | P51580 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL27399292 | 0.86 | CYP3A4 (0.61) | TSHRTP53TDP1CYP3A4SMN1; SMN2 | |
| SCHEMBL132541 | 0.86 | CYP3A4 (0.65) | TP53TDP1CYP3A4SMN1; SMN2MEN1 | |
| SCHEMBL232779 | 0.86 | TP53 (0.64) | TSHRTP53TDP1CYP3A4SMN1; SMN2 | |
| SCHEMBL29944162 | 0.86 | CYP3A4 (0.65) | TP53TDP1CYP3A4SMN1; SMN2MEN1 | |
| SCHEMBL10050753 | 0.85 | TSHR (0.63) | TSHRCYP3A4SMN1; SMN2MEN1KMT2A | |
| Acetone SCHEMBL28637824 | 0.84 | TP53 (0.58) | TSHRTP53TDP1CYP3A4SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL3088495 | 0.84 | TP53 (0.62) | TSHRTP53TDP1CYP3A4SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2299193 | 0.84 | TP53 (0.62) | TSHRTP53TDP1CYP3A4SMN1; SMN2 | |
| SCHEMBL28837773 | 0.84 | CYP3A4 (0.63) | TP53TDP1CYP3A4SMN1; SMN2MEN1 | |
| SCHEMBL9133420 | 0.84 | TP53 (0.62) | TSHRTP53TDP1CYP3A4SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120192230-A | Method for treating nitrobenzoic acid mixture as byproduct of 3-methyl-2-nitrobenzoic acid | 南昌大学 | 2025-06-24 | — | — | CN | claimed |
| CN-112618662-A | Traditional Chinese medicine formula for treating leg cramp | 栾如震 | 2021-04-09 | — | — | CN | claimed |
| CN-120192230-A | Method for treating nitrobenzoic acid mixture as byproduct of 3-methyl-2-nitrobenzoic acid | 南昌大学 | 2025-06-24 | — | — | CN | disclosed |
| CN-115066428-B | Boric acid derivatives | 首药控股(北京)股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| US-20240027902-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-25 | — | — | US | disclosed |
| CN-112441907-B | Method for co-producing mono-substituted methylbenzoic acid and mono-substituted phthalic acid | 山东友道化学有限公司 | 2023-10-31 | — | — | CN | disclosed |
| US-20230305393-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| US-20230305394-A1 | RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| US-11622970-B2 | BCL-2 inhibitors and their use as pharmaceuticals | Prelude Therapeutics Incorporation (US) | 2023-04-11 | — | — | US | disclosed |
| US-11530193-B2 | Kinase inhibitors | THE UNIVERSITY OF MANCHESTER (GB) | 2022-12-20 | — | — | US | disclosed |
| CN-115066428-A | Boronic acid derivatives | 首药控股(北京)股份有限公司 | 2022-09-16 | — | — | CN | disclosed |
| WO-1993015078-A1 | CARBAPENEMS CONTAINING A CARBOXY SUBSTITUTED PHENYL GROUP, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND USE AS ANTIBIOTICS | ZENECA LIMITED (GB) | 1993-08-05 | — | — | WO | disclosed |
| EP-0135901-B1 | HEAT-SENSITIVE REGISTRATION MATERIAL | JUJO PAPER CO., LTD. (JP) | 1988-11-30 | — | — | EP | disclosed |
| US-4705861-A | AZO DYE CHEMICAL INTERMEDIATES | BAYER AKTIENGESELLSCHAFT (DE) | 1987-11-10 | — | — | US | disclosed |
| EP-0187231-A2 | Amino phenyl benzothiazoles | BAYER AG (DE) | 1986-07-16 | — | — | EP | disclosed |
| US-4591888-A | IMPROVED STABILITY AGAINST CONTAMINATION WITH OILY SUBSTANCES | JUJO PAPER CO., LTD. (JP) | 1986-05-27 | — | — | US | disclosed |
| EP-0135901-A2 | Heat-sensitive registration material | JUJO PAPER CO., LTD. (JP) | 1985-04-03 | — | — | EP | disclosed |
| EP-0001246-B1 | PREPARATION OF 2-(3'- OR 4'-AMINOPHENYL)-5(OR 6)-AMINOBENZIMIDAZOLES | CASSELLA Aktiengesellschaft (DE) | 1981-02-25 | — | — | EP | disclosed |
| US-4192947-A | REACTING DIAMINO NITROBENZENE WITH NITROBENZOYL CHLORIDE, CYCLIZING ANILIDE IN AQUEOUS ALKALI, REDUCING NITRO GROUPS WITH SULFIDE | CASSELLA AKTIENGESELLSCHAFT (DE) | 1980-03-11 | — | — | US | disclosed |
| EP-0001246-A1 | Preparation of 2-(3'- or 4'-aminophenyl)-5(or 6)-aminobenzimidazoles | CASSELLA Aktiengesellschaft (DE) | 1979-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11622970-B2 | BCL-2 inhibitors and their use as pharmaceuticals | BCL2, BCL2L2, BCL2L1 | TSHR 3869/4885TPMT 1162/4885TP53 32/4885 |
| US-11530193-B2 | Kinase inhibitors | CAMKK2, CAMK1, CAMKK1 | TSHR 3310/4885TPMT 1519/4885TP53 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.